{"id":"W2002857087","doi":"10.1053/j.seminhematol.2012.05.004","title":"The Future of Therapy for Relapsed/Refractory Multiple Myeloma: Emerging Agents and Novel Treatment Strategies","year":2012,"lang":"en","type":"article","venue":"Seminars in Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Carfilzomib; Bortezomib; Refractory (planetary science); Panobinostat; Thalidomide; Vorinostat; Oncology; Multiple myeloma; Proteasome inhibitor; Combination therapy; Internal medicine; Ixazomib; Pharmacology; Histone deacetylase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003879286,0.0007233478,0.002453047,0.0009096612,0.0006616701,0.003223391,0.001412646,0.003089698,0.007749004],"category_scores_gemma":[0.002092644,0.0002768834,0.001227422,0.0007693384,0.001939917,0.006685818,0.001319264,0.005688269,0.001927027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001529754,"about_ca_system_score_gemma":0.002267883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007437174,"about_ca_topic_score_gemma":0.00225125,"domain_scores_codex":[0.9992718,0.000269577,0.00006848579,0.00009355757,0.0001779801,0.0001186065],"domain_scores_gemma":[0.9981872,0.001032692,0.0002215908,0.00005071835,0.0002980158,0.000209857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002281355,0.000772636,0.001338772,0.003926435,0.0001889018,0.0008383035,0.0002235883,0.001662005,0.004321703,0.03097858,0.0615005,0.8919671],"study_design_scores_gemma":[0.001446564,0.003385639,0.003938305,0.004575337,0.0006311118,0.00327752,0.0009620695,0.004019041,0.00172045,0.0758298,0.9000757,0.0001384077],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.002312009,0.9539076,0.001678546,0.03646145,0.001811493,0.00001831182,0.00006950918,0.00005551774,0.00368563],"genre_scores_gemma":[0.02448077,0.9460123,0.00509478,0.01290746,0.008933319,0.00008810472,0.0001446308,0.00002781575,0.002310888],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.007749004,"threshold_uncertainty_score":0.02592295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03592587437793413,"score_gpt":0.3444308082909432,"score_spread":0.3085049339130091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}